This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.
Journal of psychopharmacology (Oxford, England), 36(2), 151-158
Citation
Gukasyan, Natalie; Davis, Alan K; Barrett, Frederick S; Cosimano, Mary P; Sepeda, Nathan D; Johnson, Matthew W; Griffiths, Roland R. (2022). Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.. Journal of psychopharmacology (Oxford, England), 36(2), 151-158. https://doi.org/10.1177/02698811211073759